The phrase "treatment continuation" is correct and usable in written English.
You can use it when referring to the continuation of a medical treatment previously administered, such as continuing a course of antibiotics. For example: "The patient's treatment continuation will include a full evaluation and x-ray."
Treatment continuation was defined as continuous 6-MP/AZA monotherapy (without concurrent use of other CD maintenance treatment, such as methotrexate, anti-TNF agents, or natalizumab).
Treatment continuation is assessed from their medical records if the patient continues treatment at the Numazu Chuo Hospital and, if not, by asking patients via a telephone call six months post-discharge.
If treatment continuation with cisplatin is determined to be unfeasible before any progression is confirmed, continuously monotherapy of S-1 or capecitabine will be continued until PD.
The rate of treatment continuation was 85% at 1 year.
Patients who had a decrease of the serum HBV DNA of more than 0.5 logs of the basal level underwent treatment continuation with IFN-alpha combined with famciclovir (FAM) (20 mg/kg body weight per day orally) for another year.
In some patients, longer treatment continuation might be beneficial.
The 6 months follow up period was optional and reasons for treatment continuation were not formally assessed.
Nearly 90% of patients undergoing imatinib therapy experience disease progression following a significant response despite treatment continuation.
Treatment continuation varied from 31%to71%1% at week 3 of the original studies (El Mallakh et al. 2010; Keck et al. 2003; Keck et al. 2009; Sachs et al. 2006b; Vieta et al. 2005; Young et al. 2009).
Outcomes linked directly to these improvements include time between assessment and HIV testing, increases in the number agreeing to an HIV test, increases in the number of inmates who receive ART, and improved HIV treatment continuation rates.
These projected assessments are closer to the controls, indicating that at least for some of the assessments (FAS1, ICP, CIM, CV, MT, VP), treatment continuation may lead asymptotically to similar values as for the controls.
